North America Veterinary Oncology Market Size & Outlook
North America veterinary oncology market, 2018-2030 (US$M)
Related Markets
North America veterinary oncology market highlights
- The North America veterinary oncology market generated a revenue of USD 105.6 million in 2022.
- The market is expected to grow at a CAGR of 11.2% from 2023 to 2030.
- In terms of segment, radiology was the largest revenue generating therapy in 2022.
- Immunotherapy is the most lucrative therapy segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 105.6 million |
| Market revenue in 2030 | USD 246.6 million |
| Growth rate | 11.2% (CAGR from 2022 to 2030) |
| Largest segment | Radiology |
| Fastest growing segment | Immunotherapy |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Surgery, Radiology, Chemotherapy, Immunotherapy |
| Key market players worldwide | Zoetis Inc Class A, Karyopharm Therapeutics Inc, Varian, Accuray Inc, PetCure Oncology, Boehringer Ingelheim, Elanco Animal Health Inc, One Health Group, Regeneus |
Other key industry trends
- In terms of revenue, North America region accounted for 45.6% of the global veterinary oncology market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- MEA is the fastest growing regional market and is projected to reach USD 16.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Oncology Market Scope
Veterinary Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America veterinary oncology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary oncology market will help companies and investors design strategic landscapes.
Radiology was the largest segment with a revenue share of 28.03% in 2022. Horizon Databook has segmented the North America veterinary oncology market based on surgery, radiology, chemotherapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing number of veterinary cancer care centers in this region is one of the key factors driving market growth. For instance, VCA Animal Hospitals launched 35 cancer centers across North America in August 2019.
The centers were staffed by a multidisciplinary oncology group with experience in treating cancer. The market growth is expected to be driven by hospital-led initiatives in this area. Moreover, growing strategic initiatives by key players to increase access to precision medicine treatments for pet cancer in North America are boosting demand for oncology care in the region.
Reasons to subscribe to North America veterinary oncology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America veterinary oncology market databook
-
Our clientele includes a mix of veterinary oncology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America veterinary oncology market, including forecasts for subscribers. This continent databook contains high-level insights into North America veterinary oncology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America veterinary oncology market size, by country, 2016-2027 (US$M)
North America Veterinary Oncology Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
